DE SCR197

Recognizes June 2024 as Myasthenia Gravis Awareness Month in Delaware through concurrent resolution of the Senate and House of Representatives.

Identifies myasthenia gravis as a neuromuscular disorder characterized by muscle weakness and fatigue, caused by the body's immune system attacking muscle receptors that receive nerve impulses.

Notes symptoms include eyelid drooping, double vision, facial weakness, difficulty chewing and swallowing, limb weakness, and in severe cases, respiratory failure requiring mechanical ventilation (myasthenic crisis).

Cites estimated prevalence of 36,000 to 60,000 cases in the United States, with the condition likely underdiagnosed and actual prevalence higher.

Highlights the Muscle Movement Foundation's advocacy and support role for myasthenia gravis patients, using the phrase "MG can't stop me" as an awareness tool with teal as the associated awareness color.